Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > news
View:
Post by Jentai on Sep 15, 2011 3:19pm

news

https://www.fiercevaccines.com/story/medicago-unveils-new-nc-manufacturing-plant/2011-09-15

Medicago unveils new NC manufacturing plant
September 15, 2011 — 7:59am ET | By Erica Teichert


RELATED STORIES
Medicago: PhII avian flu vax trial successful
Medicago to develop vax facility in NC
Four big vax makers charge ahead with swine flu programs
Sanofi breaks ground on $477M vax plant
Manufacturers scramble to make new vax
TOOLS
Subscribe
Email
Print
Contact Author
Reprint
One year after receiving a $21 million U.S. Defense Advanced Research Projects Agency grant to develop a vaccine manufacturing facility, Medicago has opened a 97,000-square-foot plant in Research Triangle Park, NC. While the company can produce 10 million vaccine doses per month in the new facility, it is designed to ramp up production within three months for a pandemic or biological threat.
The quick turnaround wasn't the only good news for Medicago this year. The company announced in July Phase II results for its plant-based virus-like particle H5N1 vaccine. The vaccine elicited a good immune response in all patients, regardless of age. "Our rapid development and effectiveness of our vaccine candidates combined with our proven ability to build a vaccine facility in less than a year at a lower cost than traditional technologies are compelling advantages to potential partners and government agencies," said Andy Sheldon, president and CEO of Medicago, in a release.
Medicago plans to have the facility at full capacity by the end of October.

Read more: Medicago unveils new NC manufacturing plant - FierceVaccineshttps://www.fiercevaccines.com/story/medicago-unveils-new-nc-manufacturing-plant/2011-09-15#ixzz1Y3DWEnXk
Subscribe: https://www.fiercevaccines.com/signup?sourceform=Viral-Tynt-FierceVaccines-FierceVaccines
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities